VKH
OMED

Virtu KCG Holdings’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Virtu KCG Holdings’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$77K Buy
23,125
+11,975
+107% +$49.7K ﹤0.01% 2488
2017
Q1 		$103K Buy
+11,150
New +$97.9K ﹤0.01% 2674

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu KCG Holdings's OMED Position: Q2 2017 in Review

Virtu KCG Holdings increased its OncoMed Pharmaceuticals, Inc. (OMED) stake by 107% in Q2 2017, buying an estimated $49.7K and bringing the position to 23,125 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

Virtu KCG Holdings first reported a position in OMED in Q1 2017 and has held it in 2 quarters since. The position peaked at $103K in Q1 2017. 68 funds tracked by Wall St. Rank hold OMED as of Q2 2017.

  • Virtu KCG Holdings held 23,125 shares of OncoMed Pharmaceuticals, Inc. worth $77K as of Q2 2017.
  • Virtu KCG Holdings bought 11,975 OncoMed Pharmaceuticals, Inc. shares in Q2 2017, an estimated $49.7K.
  • OncoMed Pharmaceuticals, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2488 holding.
  • Virtu KCG Holdings first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2017 and has held it in 2 quarters since.
  • Virtu KCG Holdings's OncoMed Pharmaceuticals, Inc. position peaked at $103K in Q1 2017.
  • 68 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.